Tabor Jr, Regies C.
HRN: 26-39-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
03/09/2025
03/15/2025
ORAL
3.5ml
Q12
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes